Identification of A Potential Drug Target in LINC01140 (G339524)

Target Name: LINC01140

NCBI ID: G339524

Other Name(s): Long intergenic non-protein coding RNA 1140, transcript variant 2 | Long intergenic non-protein coding RNA 1140, transcript variant 1 | long intergenic non-protein coding RNA 1140 | Long intergenic non-protein coding RNA 1140, transcript variant 4 | Long intergenic non-protein coding RNA 1140, transcript variant 3 | Long intergenic non-protein coding RNA 1140, transcript variant 5 | RP5-1052I5.1

Identification of A Potential Drug Target in LINC01140

LINC01140 is a non-protein coding RNA (ncRNA) molecule that has been identified by bioinformatics analysis as containing a potential drug target in its sequence. The RNA molecule is located between the intron and exon boundaries of gene GPM22.1, which encodes the protein GLUT1. GLUT1 is a key regulator of skeletal muscle growth and repair, and is known to play a role in the development and progression of muscle diseases.

The RNA molecule has been assigned the accession number LINC01140, and is located at position 1140 on the human reference genome. It is a non-coding RNA, which means that it does not encode any protein. However, the RNA has been shown to have regulatory functions, and is involved in the regulation of gene expression.

One of the key features of LINC01140 is its location in the genomic sequence. As mentioned earlier, LINC01140 is located between the intron and exon boundaries of gene GPM22.1, which encodes the protein GLUT1. This location suggests that the RNA molecule may be involved in the regulation of GLUT1 protein synthesis and localization.

Additionally, the RNA molecule has been shown to have effects on gene expression in cell culture. For example, studies have shown that LINC01140 can inhibit the expression of GLUT1 gene in muscle cells, and can also enhance the expression of GLUT2 gene, which encodes a protein involved in muscle growth and repair.

These findings suggest that LINC01140 may be a potential drug target or biomarker for the development of muscle diseases. The inhibition of GLUT1 gene expression by LINC01140 could potentially lead to muscle growth and repair defects, which could be useful for the treatment of muscle-related diseases. Additionally, the enhancement of GLUT2 gene expression by LINC01140 could potentially lead to muscle growth and repair defects, which could be useful for the treatment of muscle-related diseases.

In conclusion, LINC01140 is a non-protein coding RNA molecule that has been identified by bioinformatics analysis as containing a potential drug target in its sequence. The RNA molecule is located between the intron and exon boundaries of gene GPM22.1, which encodes the protein GLUT1. The RNA has been shown to have regulatory functions, and is involved in the regulation of gene expression. These findings suggest that LINC01140 may be a potential drug target or biomarker for the development of muscle diseases. Further research is needed to determine the full extent of LINC01140's potential as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1140

More Common Targets